Anavex Net Income From Continuing Ops vs Operating Income Analysis
| AVXL Stock | USD 9.11 0.09 1.00% |
Anavex Life financial indicator trend analysis is way more than just evaluating Anavex Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anavex Life Sciences is a good investment. Please check the relationship between Anavex Life Net Income From Continuing Ops and its Operating Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Net Income From Continuing Ops vs Operating Income
Net Income From Continuing Ops vs Operating Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anavex Life Sciences Net Income From Continuing Ops account and Operating Income. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Anavex Life's Net Income From Continuing Ops and Operating Income is 0.98. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Operating Income in the same time period over historical financial statements of Anavex Life Sciences, assuming nothing else is changed. The correlation between historical values of Anavex Life's Net Income From Continuing Ops and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Anavex Life Sciences are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Net Income From Continuing Ops i.e., Anavex Life's Net Income From Continuing Ops and Operating Income go up and down completely randomly.
Correlation Coefficient | 0.98 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Net Income From Continuing Ops
Operating Income
Operating Income is the amount of profit realized from Anavex Life Sciences operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Anavex Life Sciences is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most indicators from Anavex Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anavex Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. At this time, Anavex Life's Selling General Administrative is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 47.1 M this year, although Enterprise Value Over EBITDA will most likely fall to (6.30).
| 2021 | 2022 | 2023 | 2024 (projected) | Tax Provision | 358.5K | 7K | 8.1K | 7.6K | Interest Income | 947.0K | 6.5M | 7.5M | 7.9M |
Anavex Life fundamental ratios Correlations
Click cells to compare fundamentals
Anavex Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Anavex Life fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
| Other Current Liab | 3.3M | 5.6M | 6.4M | 8.2M | 9.4M | 9.9M | |
| Total Current Liabilities | 7.3M | 10.8M | 10.2M | 12.5M | 14.4M | 15.1M | |
| Total Stockholder Equity | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 171.3M | |
| Net Debt | (29.2M) | (152.1M) | (149.2M) | (151.0M) | (135.9M) | (129.1M) | |
| Retained Earnings | (159.7M) | (197.6M) | (245.6M) | (293.1M) | (263.8M) | (250.6M) | |
| Cash | 29.2M | 152.1M | 149.2M | 151.0M | 173.7M | 182.4M | |
| Cash And Short Term Investments | 29.2M | 152.1M | 149.2M | 151.0M | 173.7M | 182.4M | |
| Common Stock Total Equity | 52.7K | 62.0K | 75.9K | 77.9K | 89.6K | 94.1K | |
| Common Stock Shares Outstanding | 58.2M | 69.8M | 76.9M | 79.8M | 91.8M | 96.3M | |
| Liabilities And Stockholders Equity | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
| Other Stockholder Equity | 186.9M | 348.3M | 388.0M | 434.8M | 500.1M | 525.1M | |
| Total Liab | 7.3M | 10.8M | 10.2M | 12.5M | 14.4M | 15.1M | |
| Total Current Assets | 34.5M | 161.6M | 152.7M | 154.4M | 177.5M | 186.4M | |
| Common Stock | 62.0K | 75.9K | 77.9K | 82K | 94.3K | 99.0K | |
| Accounts Payable | 4.0M | 4.7M | 3.8M | 4.3M | 5.0M | 5.2M | |
| Other Current Assets | 443.8K | 371.9K | 354K | 653K | 751.0K | 496.3K | |
| Non Current Liabilities Total | 3.3M | 5.6M | 4.3M | 7.3M | 8.4M | 8.8M | |
| Net Receivables | 4.8M | 9.1M | 3.2M | 2.7M | 3.1M | 2.1M | |
| Net Tangible Assets | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 171.3M | |
| Retained Earnings Total Equity | (133.4M) | (159.7M) | (197.6M) | (245.6M) | (221.0M) | (210.0M) | |
| Capital Surpluse | 153.6M | 186.9M | 348.3M | 388.0M | 446.2M | 468.5M | |
| Net Invested Capital | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 82.9M | |
| Net Working Capital | 27.2M | 150.8M | 142.5M | 141.9M | 163.1M | 82.9M | |
| Capital Stock | 62.0K | 75.9K | 77.9K | 82K | 94.3K | 72.7K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.